The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy

D. M. Bonifati, S. F. Witchel, M. Ermani, E. P. Hoffman, C. Angelini, E. Pegoraro

Research output: Contribution to journalArticlepeer-review


Background: Steroid administration is beneficial in Duchenne muscular dystrophy (DMD), but the response, incidence, and the severity of side effects are variable. Aims: To investigate whether glucocorticoid receptor (GRL) gene polymorphisms may be responsible for glucocorticoid sensitivity in DMD. Methods: Forty eight DMD patients treated either with prednisone or deflazacort were subjected to genetic analyses of the GRL gene. Results: Mutation studies revealed an heterozygous A to G mutation at GRL cDNA position 1220 in three DMD patients resulting in an asparagine to serine amino acid change at amino acid position 363 (N363S). The N363S carrier DMD patients showed a trend towards a later age at loss of ambulation in comparison with non-carrier patients. Conclusions: These data suggest that the N363S GRL polymorphism may be implicated in the long term response to glucocorticoids.

Original languageEnglish
Pages (from-to)1177-1179
Number of pages3
JournalJournal of Neurology, Neurosurgery and Psychiatry
Issue number10
Publication statusPublished - Oct 2006

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychiatry and Mental health


Dive into the research topics of 'The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy'. Together they form a unique fingerprint.

Cite this